Replies to post #44341 on OWC Pharmaceutical Research Corp (OWCP)

[rstar]

GWPH is spitting distance from FDA approval for i think sativex, an epilepsy drug that might also be able to be prescribed more widely? THAT is why they are given that valuation. BUT once the door is open, w FDA approving MMJ, OWC's products will have much easier regulatory passage, and they are advancing on multiple disease fronts already.

AXIM imo is a much closer comparable, as they are also OTCQB and a similar premarket MMJ pharma.

[Pussim]

GWPH trades on the NASDAQ...that makes a huge difference exactly for reasons mentioned in my previous post.
Comparing apples and oranges other than the fact we are an otcqb stock and they trade on the NAZ...
get it?
Comparisons are moot at this point.